dismiss

Garage Sale Auctions: Over 700 lots are available for a LIMITED TIME ONLY...starting at just $1! Click here to bid now!

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

FDA report opposes regulating third-party servicers Evidence for public health concern deemed 'not sufficient'

Study finds ultrasound and mammo have highest no-show rates Missed appointments at imaging facilities make up 3.25 percent of exams

Bronwen Taylor AdvaMed congratulates Stryker’s VP on 2018 PwC MedTech ethical leadership award

How SUD reprocessing delivers bigger value to health systems Lowering costs and reducing waste, the market is ripe for growth

Change Healthcare, Adobe and Microsoft partner to address patient satisfaction Big names set their attention to a big problem

Device recalls skyrocket by 126 percent in first quarter of 2018 Software accounted for nearly a quarter of all recalls

Imaging equipment leads trend toward hospital outsourcing Increasingly, hospitals are exploring outsourcing services, new survey finds

Commercial payers benefit from bundled pricing A marketplace with cost containment and better outcomes

Siemens Healthineers accrues more than $3.5 billion in second quarter Driven by growth in imaging, advanced therapies and diagnostics

Techs can interpret chest X-rays as well as radiologists: study Might help relieve imaging capacity that is being stretched worldwide

RefleXion Medical's biology-guided
radiotherapy system

RefleXion raises $100 million for world’s first biology-guided radiotherapy system

John R. Fischer , Staff Reporter
RefleXion Medical has raised more than $100 million in a Series C round of funding for the development of the first and only biology-guided radiotherapy system (BgRT) for targeted cancer treatment.

The system is designed to irradiate multiple tumors in one session, a feature that RefleXion estimates will benefit many of the 600,000 U.S. patients diagnosed with metastatic cancer each year as well as increase access to care in underserved areas that lack trained technicians and qualified staff.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"Conventional radiotherapy systems are primarily focused on treating individual, solid-tumor cancers,” RefleXion Medical CTO and co-founder Sam Mazin told HCB News. “RefleXion's technology will be able to treat that disease while also expanding the addressable patient population by treating metastatic disease, which involves multiple tumors throughout the body.”

The World Health Organization predicts that more than 13 million global cancer deaths will occur in 2030, a number which the BgRT system is predicted to help reduce, partially by simplifying and automating the radiotherapy treatment process.

The procedure will start out with a PET imaging agent administered into a patient to identify tumors, sending off signals to RefleXion’s technology so that it may direct therapeutic X-rays to one or more of these malignancies in real time.

This will enable the BgRT system to deliver higher doses of radiation than conventional systems and spare a higher amount of surrounding healthy tissue.

In addition, it will also be able to automatically compensate for tumor motion while precisely targeting the disease, a feature that according to Todd Powell, president and CEO of RefleXion, could lead to the annual diagnosis of 750,000 U.S. patients with early stage diseases.

"The funds raised will set the stage for commercialization of our unique system. That includes manufacturing, facilities and staffing in areas of marketing, sales and service" he told HCB News.

Funding for this round was led by the Rise Fund, the global impact investment fund managed by TPG Growth, marking its first investment in health care technology.

Contributions were also made by T. Rowe Price Associates Inc.; China-focused health care investment firm GT Healthcare Capital Partners; Sofinnova Partners; KCK Group; Venrock; Pfizer Venture Investments; and Johnson & Johnson Innovation – JJDC Inc.

RefleXion Medical expects to be treating U.S. patients by mid-2019.

Back to HCB News
  Pages: 1

Business Affairs Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有